Can Ozempic Trigger Bone Weakness During Weight Loss?
Ozempic® (semaglutide) is administered via a once-weekly injection to assist individuals with type 2 diabetes in regulating their blood sugar. It is also effective for those with excess weight and obesity seeking to lose weight. Concerns regarding the medication's potential adverse effects on bone health have surfaced.
Does Ozempic® lead to bone loss? Current evidence does not establish a direct correlation between Ozempic® and bone loss or osteoporosis. However, substantial weight reduction, a common outcome of Ozempic® treatment, might contribute to decreased bone density.
The following sections will examine the existing knowledge about Ozempic® and bone loss, along with strategies for safeguarding bone health while using this medication.
Does Ozempic® Cause Bone Loss? If So, How?
Further investigation is necessary to ascertain whether Ozempic® can induce bone loss. Certain studies suggest a connection between Ozempic® and reduced bone density (osteopenia). Nevertheless, this could be attributed to the weight loss facilitated by Ozempic® rather than the drug itself.
Research on Ozempic® Bone Density Loss
A 2024 study, involving individuals at a heightened risk of bone fractures, particularly post-menopausal women, divided participants into two groups: one receiving a 0.5 mg dose of Ozempic®, and the other a placebo, for a duration of one year.
The study's conclusion indicated no significant disparities in bone formation between the Ozempic® and placebo groups.
Conversely, the Ozempic® group exhibited lower bone mineral density in the lower spine and hip regions, potentially indicating bone weakening. Additionally, an indicator of bone resorption, a natural process of bone breakdown, was elevated in the Ozempic® group.
Researchers posited that these findings might stem from weight loss rather than a direct effect of Ozempic®.
However, research findings present a mixed picture. A systematic review analyzing glucagon-like peptide-1 receptor agonists (GLP-1s), the drug class to which Ozempic® belongs, determined that GLP-1 medications did not impact bone mineral density and were not associated with a higher risk of fractures.
Ozempic® and Osteoporosis
Research has not established a connection between Ozempic® and osteoporosis, a condition characterized by fragile and brittle bones.
A clinical trial focusing on Wegovy®, which contains a higher semaglutide dosage, identified an increased fracture risk in women and older individuals. However, fractures remained infrequent, reported in 1% of women and 2.4% of individuals over 75 using the medication.
How Weight Loss Affects Your Bones
Any bone alterations observed during Ozempic® treatment may be linked to weight loss.
Substantial weight reduction diminishes mechanical loading, the stress exerted on bones that contributes to their strength.
Moreover, weight loss may lead to decreased nutrient intake, including insufficient protein, calcium, or vitamin D, all vital for maintaining healthy bones. Hormonal fluctuations can also influence bone density.
Lastly, muscle mass loss can accompany fat mass reduction, and bone mineral density is correlated with muscle mass.
How to Protect Your Bones While You're Losing Weight With Ozempic®
To safeguard your bones during weight loss with Ozempic®, prioritize a nutrient-rich diet containing adequate calcium, vitamin D, and protein. Incorporating strength training and promoting gradual weight loss can also be beneficial. Health tracking apps like Shotlee can help monitor your diet and exercise routine.
Let's delve into these recommendations in greater detail.
1. Get Enough Calcium, Vitamin D, and Protein
While pursuing weight loss, ensure sufficient nutrient intake to support bone health, particularly calcium, vitamin D, and protein.
Calcium sources include:
- Low-fat milk, yogurt, and cheese
- Fortified soy products
- Salmon
- Spinach
- Kale
- Fortified milk alternatives
Vitamin D sources include:

